Global Prostate-specific Antigen (PSA) Testing Market Growth (Status and Outlook) 2025-2031
According to this study, the global Prostate-specific Antigen (PSA) Testing market size will reach US$ 652 million by 2031.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la?
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th?
LPI (LP Information)' newest research report, the “Prostate-specific Antigen (PSA) Testing Industry Forecast” looks at past sales and reviews total world Prostate-specific Antigen (PSA) Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate-specific Antigen (PSA) Testing sales for 2025 through 2031. With Prostate-specific Antigen (PSA) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-specific Antigen (PSA) Testing industry.
This Insight Report provides a comprehensive analysis of the global Prostate-specific Antigen (PSA) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate-specific Antigen (PSA) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-specific Antigen (PSA) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-specific Antigen (PSA) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-specific Antigen (PSA) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-specific Antigen (PSA) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la?
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th?
LPI (LP Information)' newest research report, the “Prostate-specific Antigen (PSA) Testing Industry Forecast” looks at past sales and reviews total world Prostate-specific Antigen (PSA) Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate-specific Antigen (PSA) Testing sales for 2025 through 2031. With Prostate-specific Antigen (PSA) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-specific Antigen (PSA) Testing industry.
This Insight Report provides a comprehensive analysis of the global Prostate-specific Antigen (PSA) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate-specific Antigen (PSA) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-specific Antigen (PSA) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-specific Antigen (PSA) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-specific Antigen (PSA) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-specific Antigen (PSA) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CLIA Method
- ELISA Method
- Screening
- Post-treatment Monitoring
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Boston Scientific Corporation
- Bayer AG
- Siemens Healthcare
- DiaSorin
- Roche
- Beckman Coulter
- PerkinElmer
- Tosoh
- Ortho Clinical
- Fujirebio
- Mediwatch
- BodiTech
- Bristol-Myers Squibb Company
- GE Healthcare
- Endocare
- Merck?Co.
- Medtronic
- Sanofi-Aventis SA
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate-specific Antigen (PSA) Testing Market Size (2020-2031)
2.1.2 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Prostate-specific Antigen (PSA) Testing by Country/Region (2020, 2024 & 2031)
2.2 Prostate-specific Antigen (PSA) Testing Segment by Type
2.2.1 CLIA Method
2.2.2 ELISA Method
2.3 Prostate-specific Antigen (PSA) Testing Market Size by Type
2.3.1 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
2.4 Prostate-specific Antigen (PSA) Testing Segment by Application
2.4.1 Screening
2.4.2 Post-treatment Monitoring
2.4.3 Other
2.5 Prostate-specific Antigen (PSA) Testing Market Size by Application
2.5.1 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
3 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE BY PLAYER
3.1 Prostate-specific Antigen (PSA) Testing Market Size Market Share by Player
3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by Player (2020-2025)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player (2020-2025)
3.2 Global Prostate-specific Antigen (PSA) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING BY REGION
4.1 Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025)
4.2 Global Prostate-specific Antigen (PSA) Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.4 APAC Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.5 Europe Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025)
5.2 Americas Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
5.3 Americas Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025)
6.2 APAC Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
6.3 APAC Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing by Region (2020-2025)
8.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET FORECAST
10.1 Global Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.1.1 Global Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.1.2 Americas Prostate-specific Antigen (PSA) Testing Forecast
10.1.3 APAC Prostate-specific Antigen (PSA) Testing Forecast
10.1.4 Europe Prostate-specific Antigen (PSA) Testing Forecast
10.1.5 Middle East & Africa Prostate-specific Antigen (PSA) Testing Forecast
10.2 Americas Prostate-specific Antigen (PSA) Testing Forecast by Country (2026-2031)
10.2.1 United States Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.2 Canada Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.3 Mexico Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.4 Brazil Market Prostate-specific Antigen (PSA) Testing Forecast
10.3 APAC Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.3.1 China Prostate-specific Antigen (PSA) Testing Market Forecast
10.3.2 Japan Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.3 Korea Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.4 Southeast Asia Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.5 India Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.6 Australia Market Prostate-specific Antigen (PSA) Testing Forecast
10.4 Europe Prostate-specific Antigen (PSA) Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.2 France Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.3 UK Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.4 Italy Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.5 Russia Market Prostate-specific Antigen (PSA) Testing Forecast
10.5 Middle East & Africa Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.2 South Africa Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.3 Israel Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.4 Turkey Market Prostate-specific Antigen (PSA) Testing Forecast
10.6 Global Prostate-specific Antigen (PSA) Testing Forecast by Type (2026-2031)
10.7 Global Prostate-specific Antigen (PSA) Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Prostate-specific Antigen (PSA) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Prostate-specific Antigen (PSA) Testing Product Offered
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Information
11.2.2 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Offered
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Boston Scientific Corporation Main Business Overview
11.2.5 Boston Scientific Corporation Latest Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Prostate-specific Antigen (PSA) Testing Product Offered
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bayer AG Main Business Overview
11.3.5 Bayer AG Latest Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Information
11.4.2 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Siemens Healthcare Main Business Overview
11.4.5 Siemens Healthcare Latest Developments
11.5 DiaSorin
11.5.1 DiaSorin Company Information
11.5.2 DiaSorin Prostate-specific Antigen (PSA) Testing Product Offered
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DiaSorin Main Business Overview
11.5.5 DiaSorin Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Prostate-specific Antigen (PSA) Testing Product Offered
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Information
11.7.2 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Offered
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Beckman Coulter Main Business Overview
11.7.5 Beckman Coulter Latest Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Information
11.8.2 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Offered
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 PerkinElmer Main Business Overview
11.8.5 PerkinElmer Latest Developments
11.9 Tosoh
11.9.1 Tosoh Company Information
11.9.2 Tosoh Prostate-specific Antigen (PSA) Testing Product Offered
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Tosoh Main Business Overview
11.9.5 Tosoh Latest Developments
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Information
11.10.2 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Offered
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ortho Clinical Main Business Overview
11.10.5 Ortho Clinical Latest Developments
11.11 Fujirebio
11.11.1 Fujirebio Company Information
11.11.2 Fujirebio Prostate-specific Antigen (PSA) Testing Product Offered
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fujirebio Main Business Overview
11.11.5 Fujirebio Latest Developments
11.12 Mediwatch
11.12.1 Mediwatch Company Information
11.12.2 Mediwatch Prostate-specific Antigen (PSA) Testing Product Offered
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mediwatch Main Business Overview
11.12.5 Mediwatch Latest Developments
11.13 BodiTech
11.13.1 BodiTech Company Information
11.13.2 BodiTech Prostate-specific Antigen (PSA) Testing Product Offered
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 BodiTech Main Business Overview
11.13.5 BodiTech Latest Developments
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Information
11.14.2 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Offered
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Bristol-Myers Squibb Company Main Business Overview
11.14.5 Bristol-Myers Squibb Company Latest Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Information
11.15.2 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 GE Healthcare Main Business Overview
11.15.5 GE Healthcare Latest Developments
11.16 Endocare
11.16.1 Endocare Company Information
11.16.2 Endocare Prostate-specific Antigen (PSA) Testing Product Offered
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Endocare Main Business Overview
11.16.5 Endocare Latest Developments
11.17 Merck?Co.
11.17.1 Merck?Co. Company Information
11.17.2 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Offered
11.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Merck?Co. Main Business Overview
11.17.5 Merck?Co. Latest Developments
11.18 Medtronic
11.18.1 Medtronic Company Information
11.18.2 Medtronic Prostate-specific Antigen (PSA) Testing Product Offered
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Medtronic Main Business Overview
11.18.5 Medtronic Latest Developments
11.19 Sanofi-Aventis SA
11.19.1 Sanofi-Aventis SA Company Information
11.19.2 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Offered
11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Sanofi-Aventis SA Main Business Overview
11.19.5 Sanofi-Aventis SA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate-specific Antigen (PSA) Testing Market Size (2020-2031)
2.1.2 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Prostate-specific Antigen (PSA) Testing by Country/Region (2020, 2024 & 2031)
2.2 Prostate-specific Antigen (PSA) Testing Segment by Type
2.2.1 CLIA Method
2.2.2 ELISA Method
2.3 Prostate-specific Antigen (PSA) Testing Market Size by Type
2.3.1 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
2.4 Prostate-specific Antigen (PSA) Testing Segment by Application
2.4.1 Screening
2.4.2 Post-treatment Monitoring
2.4.3 Other
2.5 Prostate-specific Antigen (PSA) Testing Market Size by Application
2.5.1 Prostate-specific Antigen (PSA) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
3 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE BY PLAYER
3.1 Prostate-specific Antigen (PSA) Testing Market Size Market Share by Player
3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by Player (2020-2025)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player (2020-2025)
3.2 Global Prostate-specific Antigen (PSA) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING BY REGION
4.1 Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025)
4.2 Global Prostate-specific Antigen (PSA) Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.4 APAC Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.5 Europe Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025)
5.2 Americas Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
5.3 Americas Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025)
6.2 APAC Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
6.3 APAC Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing by Region (2020-2025)
8.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET FORECAST
10.1 Global Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.1.1 Global Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.1.2 Americas Prostate-specific Antigen (PSA) Testing Forecast
10.1.3 APAC Prostate-specific Antigen (PSA) Testing Forecast
10.1.4 Europe Prostate-specific Antigen (PSA) Testing Forecast
10.1.5 Middle East & Africa Prostate-specific Antigen (PSA) Testing Forecast
10.2 Americas Prostate-specific Antigen (PSA) Testing Forecast by Country (2026-2031)
10.2.1 United States Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.2 Canada Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.3 Mexico Market Prostate-specific Antigen (PSA) Testing Forecast
10.2.4 Brazil Market Prostate-specific Antigen (PSA) Testing Forecast
10.3 APAC Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.3.1 China Prostate-specific Antigen (PSA) Testing Market Forecast
10.3.2 Japan Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.3 Korea Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.4 Southeast Asia Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.5 India Market Prostate-specific Antigen (PSA) Testing Forecast
10.3.6 Australia Market Prostate-specific Antigen (PSA) Testing Forecast
10.4 Europe Prostate-specific Antigen (PSA) Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.2 France Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.3 UK Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.4 Italy Market Prostate-specific Antigen (PSA) Testing Forecast
10.4.5 Russia Market Prostate-specific Antigen (PSA) Testing Forecast
10.5 Middle East & Africa Prostate-specific Antigen (PSA) Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.2 South Africa Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.3 Israel Market Prostate-specific Antigen (PSA) Testing Forecast
10.5.4 Turkey Market Prostate-specific Antigen (PSA) Testing Forecast
10.6 Global Prostate-specific Antigen (PSA) Testing Forecast by Type (2026-2031)
10.7 Global Prostate-specific Antigen (PSA) Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Prostate-specific Antigen (PSA) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Prostate-specific Antigen (PSA) Testing Product Offered
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Information
11.2.2 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Offered
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Boston Scientific Corporation Main Business Overview
11.2.5 Boston Scientific Corporation Latest Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Prostate-specific Antigen (PSA) Testing Product Offered
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bayer AG Main Business Overview
11.3.5 Bayer AG Latest Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Information
11.4.2 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Siemens Healthcare Main Business Overview
11.4.5 Siemens Healthcare Latest Developments
11.5 DiaSorin
11.5.1 DiaSorin Company Information
11.5.2 DiaSorin Prostate-specific Antigen (PSA) Testing Product Offered
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DiaSorin Main Business Overview
11.5.5 DiaSorin Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Prostate-specific Antigen (PSA) Testing Product Offered
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Information
11.7.2 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Offered
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Beckman Coulter Main Business Overview
11.7.5 Beckman Coulter Latest Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Information
11.8.2 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Offered
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 PerkinElmer Main Business Overview
11.8.5 PerkinElmer Latest Developments
11.9 Tosoh
11.9.1 Tosoh Company Information
11.9.2 Tosoh Prostate-specific Antigen (PSA) Testing Product Offered
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Tosoh Main Business Overview
11.9.5 Tosoh Latest Developments
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Information
11.10.2 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Offered
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ortho Clinical Main Business Overview
11.10.5 Ortho Clinical Latest Developments
11.11 Fujirebio
11.11.1 Fujirebio Company Information
11.11.2 Fujirebio Prostate-specific Antigen (PSA) Testing Product Offered
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fujirebio Main Business Overview
11.11.5 Fujirebio Latest Developments
11.12 Mediwatch
11.12.1 Mediwatch Company Information
11.12.2 Mediwatch Prostate-specific Antigen (PSA) Testing Product Offered
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mediwatch Main Business Overview
11.12.5 Mediwatch Latest Developments
11.13 BodiTech
11.13.1 BodiTech Company Information
11.13.2 BodiTech Prostate-specific Antigen (PSA) Testing Product Offered
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 BodiTech Main Business Overview
11.13.5 BodiTech Latest Developments
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Information
11.14.2 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Offered
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Bristol-Myers Squibb Company Main Business Overview
11.14.5 Bristol-Myers Squibb Company Latest Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Information
11.15.2 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 GE Healthcare Main Business Overview
11.15.5 GE Healthcare Latest Developments
11.16 Endocare
11.16.1 Endocare Company Information
11.16.2 Endocare Prostate-specific Antigen (PSA) Testing Product Offered
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Endocare Main Business Overview
11.16.5 Endocare Latest Developments
11.17 Merck?Co.
11.17.1 Merck?Co. Company Information
11.17.2 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Offered
11.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Merck?Co. Main Business Overview
11.17.5 Merck?Co. Latest Developments
11.18 Medtronic
11.18.1 Medtronic Company Information
11.18.2 Medtronic Prostate-specific Antigen (PSA) Testing Product Offered
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Medtronic Main Business Overview
11.18.5 Medtronic Latest Developments
11.19 Sanofi-Aventis SA
11.19.1 Sanofi-Aventis SA Company Information
11.19.2 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Offered
11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Sanofi-Aventis SA Main Business Overview
11.19.5 Sanofi-Aventis SA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Prostate-specific Antigen (PSA) Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CLIA Method
Table 4. Major Players of ELISA Method
Table 5. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Table 8. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Table 11. Global Prostate-specific Antigen (PSA) Testing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player (2020-2025)
Table 13. Prostate-specific Antigen (PSA) Testing Key Players Head office and Products Offered
Table 14. Prostate-specific Antigen (PSA) Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Table 19. Global Prostate-specific Antigen (PSA) Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country (2020-2025)
Table 23. Americas Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Table 25. Americas Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Table 27. APAC Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Table 29. APAC Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country (2020-2025)
Table 33. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Prostate-specific Antigen (PSA) Testing
Table 39. Key Market Challenges & Risks of Prostate-specific Antigen (PSA) Testing
Table 40. Key Industry Trends of Prostate-specific Antigen (PSA) Testing
Table 41. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 46. Abbott Prostate-specific Antigen (PSA) Testing Product Offered
Table 47. Abbott Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Main Business
Table 49. Abbott Latest Developments
Table 50. Boston Scientific Corporation Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 51. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Offered
Table 52. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Boston Scientific Corporation Main Business
Table 54. Boston Scientific Corporation Latest Developments
Table 55. Bayer AG Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 56. Bayer AG Prostate-specific Antigen (PSA) Testing Product Offered
Table 57. Bayer AG Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer AG Main Business
Table 59. Bayer AG Latest Developments
Table 60. Siemens Healthcare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 61. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
Table 62. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Siemens Healthcare Main Business
Table 64. Siemens Healthcare Latest Developments
Table 65. DiaSorin Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 66. DiaSorin Prostate-specific Antigen (PSA) Testing Product Offered
Table 67. DiaSorin Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DiaSorin Main Business
Table 69. DiaSorin Latest Developments
Table 70. Roche Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 71. Roche Prostate-specific Antigen (PSA) Testing Product Offered
Table 72. Roche Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Beckman Coulter Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 76. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Offered
Table 77. Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Beckman Coulter Main Business
Table 79. Beckman Coulter Latest Developments
Table 80. PerkinElmer Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 81. PerkinElmer Prostate-specific Antigen (PSA) Testing Product Offered
Table 82. PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. PerkinElmer Main Business
Table 84. PerkinElmer Latest Developments
Table 85. Tosoh Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 86. Tosoh Prostate-specific Antigen (PSA) Testing Product Offered
Table 87. Tosoh Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Tosoh Main Business
Table 89. Tosoh Latest Developments
Table 90. Ortho Clinical Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 91. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Offered
Table 92. Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ortho Clinical Main Business
Table 94. Ortho Clinical Latest Developments
Table 95. Fujirebio Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 96. Fujirebio Prostate-specific Antigen (PSA) Testing Product Offered
Table 97. Fujirebio Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Fujirebio Main Business
Table 99. Fujirebio Latest Developments
Table 100. Mediwatch Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 101. Mediwatch Prostate-specific Antigen (PSA) Testing Product Offered
Table 102. Mediwatch Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Mediwatch Main Business
Table 104. Mediwatch Latest Developments
Table 105. BodiTech Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 106. BodiTech Prostate-specific Antigen (PSA) Testing Product Offered
Table 107. BodiTech Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. BodiTech Main Business
Table 109. BodiTech Latest Developments
Table 110. Bristol-Myers Squibb Company Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 111. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Offered
Table 112. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Bristol-Myers Squibb Company Main Business
Table 114. Bristol-Myers Squibb Company Latest Developments
Table 115. GE Healthcare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 116. GE Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
Table 117. GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. GE Healthcare Main Business
Table 119. GE Healthcare Latest Developments
Table 120. Endocare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 121. Endocare Prostate-specific Antigen (PSA) Testing Product Offered
Table 122. Endocare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Endocare Main Business
Table 124. Endocare Latest Developments
Table 125. Merck?Co. Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 126. Merck?Co. Prostate-specific Antigen (PSA) Testing Product Offered
Table 127. Merck?Co. Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Merck?Co. Main Business
Table 129. Merck?Co. Latest Developments
Table 130. Medtronic Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 131. Medtronic Prostate-specific Antigen (PSA) Testing Product Offered
Table 132. Medtronic Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Medtronic Main Business
Table 134. Medtronic Latest Developments
Table 135. Sanofi-Aventis SA Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 136. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Offered
Table 137. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Sanofi-Aventis SA Main Business
Table 139. Sanofi-Aventis SA Latest Developments
Table 1. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Prostate-specific Antigen (PSA) Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CLIA Method
Table 4. Major Players of ELISA Method
Table 5. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Table 8. Prostate-specific Antigen (PSA) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Table 11. Global Prostate-specific Antigen (PSA) Testing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player (2020-2025)
Table 13. Prostate-specific Antigen (PSA) Testing Key Players Head office and Products Offered
Table 14. Prostate-specific Antigen (PSA) Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Table 19. Global Prostate-specific Antigen (PSA) Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country (2020-2025)
Table 23. Americas Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Table 25. Americas Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Table 27. APAC Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Table 29. APAC Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country (2020-2025)
Table 33. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Prostate-specific Antigen (PSA) Testing
Table 39. Key Market Challenges & Risks of Prostate-specific Antigen (PSA) Testing
Table 40. Key Industry Trends of Prostate-specific Antigen (PSA) Testing
Table 41. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 46. Abbott Prostate-specific Antigen (PSA) Testing Product Offered
Table 47. Abbott Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Main Business
Table 49. Abbott Latest Developments
Table 50. Boston Scientific Corporation Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 51. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Offered
Table 52. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Boston Scientific Corporation Main Business
Table 54. Boston Scientific Corporation Latest Developments
Table 55. Bayer AG Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 56. Bayer AG Prostate-specific Antigen (PSA) Testing Product Offered
Table 57. Bayer AG Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer AG Main Business
Table 59. Bayer AG Latest Developments
Table 60. Siemens Healthcare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 61. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
Table 62. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Siemens Healthcare Main Business
Table 64. Siemens Healthcare Latest Developments
Table 65. DiaSorin Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 66. DiaSorin Prostate-specific Antigen (PSA) Testing Product Offered
Table 67. DiaSorin Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DiaSorin Main Business
Table 69. DiaSorin Latest Developments
Table 70. Roche Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 71. Roche Prostate-specific Antigen (PSA) Testing Product Offered
Table 72. Roche Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Beckman Coulter Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 76. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Offered
Table 77. Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Beckman Coulter Main Business
Table 79. Beckman Coulter Latest Developments
Table 80. PerkinElmer Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 81. PerkinElmer Prostate-specific Antigen (PSA) Testing Product Offered
Table 82. PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. PerkinElmer Main Business
Table 84. PerkinElmer Latest Developments
Table 85. Tosoh Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 86. Tosoh Prostate-specific Antigen (PSA) Testing Product Offered
Table 87. Tosoh Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Tosoh Main Business
Table 89. Tosoh Latest Developments
Table 90. Ortho Clinical Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 91. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Offered
Table 92. Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ortho Clinical Main Business
Table 94. Ortho Clinical Latest Developments
Table 95. Fujirebio Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 96. Fujirebio Prostate-specific Antigen (PSA) Testing Product Offered
Table 97. Fujirebio Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Fujirebio Main Business
Table 99. Fujirebio Latest Developments
Table 100. Mediwatch Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 101. Mediwatch Prostate-specific Antigen (PSA) Testing Product Offered
Table 102. Mediwatch Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Mediwatch Main Business
Table 104. Mediwatch Latest Developments
Table 105. BodiTech Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 106. BodiTech Prostate-specific Antigen (PSA) Testing Product Offered
Table 107. BodiTech Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. BodiTech Main Business
Table 109. BodiTech Latest Developments
Table 110. Bristol-Myers Squibb Company Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 111. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Offered
Table 112. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Bristol-Myers Squibb Company Main Business
Table 114. Bristol-Myers Squibb Company Latest Developments
Table 115. GE Healthcare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 116. GE Healthcare Prostate-specific Antigen (PSA) Testing Product Offered
Table 117. GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. GE Healthcare Main Business
Table 119. GE Healthcare Latest Developments
Table 120. Endocare Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 121. Endocare Prostate-specific Antigen (PSA) Testing Product Offered
Table 122. Endocare Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Endocare Main Business
Table 124. Endocare Latest Developments
Table 125. Merck?Co. Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 126. Merck?Co. Prostate-specific Antigen (PSA) Testing Product Offered
Table 127. Merck?Co. Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Merck?Co. Main Business
Table 129. Merck?Co. Latest Developments
Table 130. Medtronic Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 131. Medtronic Prostate-specific Antigen (PSA) Testing Product Offered
Table 132. Medtronic Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Medtronic Main Business
Table 134. Medtronic Latest Developments
Table 135. Sanofi-Aventis SA Details, Company Type, Prostate-specific Antigen (PSA) Testing Area Served and Its Competitors
Table 136. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Offered
Table 137. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Sanofi-Aventis SA Main Business
Table 139. Sanofi-Aventis SA Latest Developments
LIST OF FIGURES
Figure 1. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Prostate-specific Antigen (PSA) Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Prostate-specific Antigen (PSA) Testing Sales Market Share by Country/Region (2024)
Figure 8. Prostate-specific Antigen (PSA) Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type in 2024
Figure 10. Prostate-specific Antigen (PSA) Testing in Screening
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market: Screening (2020-2025) & ($ millions)
Figure 12. Prostate-specific Antigen (PSA) Testing in Post-treatment Monitoring
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market: Post-treatment Monitoring (2020-2025) & ($ millions)
Figure 14. Prostate-specific Antigen (PSA) Testing in Other
Figure 15. Global Prostate-specific Antigen (PSA) Testing Market: Other (2020-2025) & ($ millions)
Figure 16. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application in 2024
Figure 17. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player in 2024
Figure 18. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas Prostate-specific Antigen (PSA) Testing Value Market Share by Country in 2024
Figure 24. United States Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region in 2024
Figure 29. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 30. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 31. China Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country in 2024
Figure 38. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 39. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 41. France Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 57. United States Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 61. China Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 65. India Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 68. France Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 69. UK Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 75. Turkey Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 76. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 1. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Prostate-specific Antigen (PSA) Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Prostate-specific Antigen (PSA) Testing Sales Market Share by Country/Region (2024)
Figure 8. Prostate-specific Antigen (PSA) Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type in 2024
Figure 10. Prostate-specific Antigen (PSA) Testing in Screening
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market: Screening (2020-2025) & ($ millions)
Figure 12. Prostate-specific Antigen (PSA) Testing in Post-treatment Monitoring
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market: Post-treatment Monitoring (2020-2025) & ($ millions)
Figure 14. Prostate-specific Antigen (PSA) Testing in Other
Figure 15. Global Prostate-specific Antigen (PSA) Testing Market: Other (2020-2025) & ($ millions)
Figure 16. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application in 2024
Figure 17. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Player in 2024
Figure 18. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas Prostate-specific Antigen (PSA) Testing Value Market Share by Country in 2024
Figure 24. United States Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region in 2024
Figure 29. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 30. APAC Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 31. China Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Country in 2024
Figure 38. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 39. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 41. France Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 57. United States Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 61. China Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 65. India Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 68. France Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 69. UK Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 75. Turkey Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
Figure 76. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Prostate-specific Antigen (PSA) Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size 2026-2031 ($ millions)
